$ARIA News Six stocks to watch 3:27 p.m. Feb. 26, 2014

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 10:17 AM

$ARIA News

Six stocks to watch 3:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 3:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com

'Fast Money' Recap: Should You Buy European or U.S. Stocks? 5:00 a.m. Today - TheStreet.com
Can Radius Health (RDUS) Surprise This Earnings Season? - Analyst Blog 10:06 a.m. Feb. 13, 2015 - Zacks.com
Hottest Healthcare Stocks Now – GSK ARIA CNMD SLXP 5:30 a.m. Feb. 13, 2015 - InvestorPlace.com
Will Immune Design (IMDZ) Miss on Earnings This Season? - Analyst Blog 2:40 p.m. Feb. 10, 2015 - Zacks.com
Will Ligand Pharmaceuticals (LGND) Miss on Earnings in Q4? - Analyst Blog 9:54 a.m. Feb. 6, 2015 - Zacks.com
Will Pacific Biosciences (PACB) Surprise on Earnings in Q4? - Analyst Blog 4:40 p.m. Feb. 2, 2015 - Zacks.com
Will GW Pharmaceuticals (GWPH) Miss this Earnings Season? - Analyst Blog 2:40 p.m. Feb. 2, 2015 - Zacks.com
3 Biotechs Looking Good this Earnings Season - Earnings ESP 12:38 p.m. Jan. 30, 2015 - Zacks.com
ARIAD: The Worst May Not Be Over 11:15 a.m. Jan. 28, 2015 - Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Flagged As Strong On High Volume 10:01 a.m. Jan. 28, 2015 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ABMD ARIA WOOF MNKD 5:45 a.m. Jan. 28, 2015 - InvestorPlace.com
InsiderInsights.com Daily Round Up 1/26/15: THRM, FXCM, OPK, TCBI 4:00 a.m. Jan. 28, 2015 - Seeking Alpha
10 Biotechnology Stocks to Sell Now 3:45 a.m. Jan. 28, 2015 - InvestorPlace.com
Earnings Peek: ARIAD Should Easily Beat Outdated Estimates 2:19 p.m. Jan. 27, 2015 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ARIA MYGN NVS MNKD 5:30 a.m. Jan. 27, 2015 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – LCI HCA MNKD INCY 5:45 a.m. Jan. 26, 2015 - InvestorPlace.com
Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More 4:00 p.m. Jan. 23, 2015 - Seeking Alpha
ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog 2:00 p.m. Jan. 21, 2015 - Zacks.com
ARIAD Pharmaceuticals: Is The Ship Turning Around? 11:07 a.m. Jan. 21, 2015 - Seeking Alpha
Hottest Healthcare Stocks Now – NVO CLDX ZLTQ ARIA 5:15 a.m. Jan. 20, 2015 - InvestorPlace.com

What's New in the Pharma Sector: New Research on Amgen, Applied Genetic Technologies, Aptose, ARIAD, and Atara Biotherapeutics 7:40 a.m. Feb. 13, 2015 - PR Newswire - PRF
ARIAD to Present at the RBC Capital Markets’ Healthcare Conference 7:35 a.m. Feb. 11, 2015 - BusinessWire - BZX
Critical Alerts For LinkedIn, Ariad Pharmaceuticals, Tableau Software, Nu Skin Enterprises and CBS Released By InvestorsObserver 9:31 a.m. Feb. 6, 2015 - PR Newswire - PRF
Biotech Stocks Scanner - ARIAD Pharma, Celgene, CytRx, Amicus Therapeutics, and United Therapeutics 9:00 a.m. Feb. 4, 2015 - PR Newswire - PRF
ARIAD to Present at the Leerink Global Healthcare Conference 7:35 a.m. Feb. 3, 2015 - BusinessWire - BZX
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2014 Financial Results 7:35 a.m. Jan. 29, 2015 - BusinessWire - BZX
Insider Trading Alerts for FXCM, Achillion Pharmaceuticals, Ariad Pharmaceuticals, Kinder Morgan, Twitter, and Yahoo 8:45 a.m. Jan. 27, 2015 - PR Newswire - PRF
Insider Trading Research for Delta Air Lines, Ariad Pharmaceuticals, Alcoa, Avon, FXCM, and Apple 8:45 a.m. Jan. 23, 2015 - PR Newswire - PRF
ARIAD Announces Appointment of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, as Chief Legal and Administrative Officer 7:35 a.m. Jan. 22, 2015 - BusinessWire - BZX
ARIAD Announces Final Decision from European Commission Endorsing Iclusig’s Approved Indications Throughout Europe 7:35 a.m. Jan. 20, 2015 - BusinessWire - BZX
ARIAD Announces Key Strategic Objectives for 2015 Expected to Lead Company to Profitability in Three Years 7:35 a.m. Jan. 13, 2015 - BusinessWire - BZX
ARIAD Announces Phase 2 Dose-Ranging Trial of Iclusig (Ponatinib) to Begin by Mid-2015 7:35 a.m. Jan. 6, 2015 - BusinessWire - BZX
Striking Deals on Street: New Research on State Investors, NCI, Ariad, Under Armour and Meadowbrook 9:20 a.m. Dec. 31, 2014 - PR Newswire - PRF
ARIAD Announces Commercialization Agreement for Iclusig in Seven Central and Eastern European Countries 7:35 a.m. Dec. 30, 2014 - BusinessWire - BZX
ARIAD To Present at The 33rd Annual J.P. Morgan Healthcare Conference 7:35 a.m. Dec. 22, 2014 - BusinessWire - BZX
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma 9:15 a.m. Dec. 18, 2014 - PR Newswire - PRF
ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial 7:35 a.m. Dec. 8, 2014 - BusinessWire - BZX
Insider Trading Alerts for Hertz, Ariad Pharmaceuticals, J C Penney, Sirius XM, Apple, and Sunedison 8:45 a.m. Nov. 25, 2014 - PR Newswire - PRF
ARIAD and STA Announce Approval of Iclusig (Ponatinib) in Australia 7:35 a.m. Nov. 24, 2014 - BusinessWire - BZX
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Protecting Teeth: Insights from Endodontist Dr. Joubert

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...